Literature DB >> 2117826

UDP-glucuronosyltransferases: a family of detoxifying enzymes.

T R Tephly1, B Burchell.   

Abstract

Glucuronidation is an important process in the metabolism of xenobiotic and endogenous substances leading to enhancement of excretion of these compounds from the body. A multigene family encodes a number of UDP-glucuronosyltransferase enzymes which catalyse this route of metabolism. Recent advances in biochemical and molecular biological approaches, reviewed here by Thomas Tephly and Brian Burchell, have given new insight into the function and structure of UDP-glucuronosyltransferases. These proteins have surprising similarities and yet appear to be capable of conjugating a remarkable number of different chemicals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117826     DOI: 10.1016/0165-6147(90)90008-v

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  46 in total

1.  Lack of effect of paracetamol on the pharmacokinetics and metabolism of codeine in man.

Authors:  A Somogyi; F Bochner; Z R Chen
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Cloning and stable expression of a new member of the human liver phenol/bilirubin: UDP-glucuronosyltransferase cDNA family.

Authors:  R Wooster; L Sutherland; T Ebner; D Clarke; O Da Cruz e Silva; B Burchell
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

Review 3.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

4.  Structure of the human UGT2B4 gene encoding a bile acid UDP-glucuronosyltransferase.

Authors:  G Monaghan; B Burchell; M Boxer
Journal:  Mamm Genome       Date:  1997-09       Impact factor: 2.957

Review 5.  Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.

Authors:  M Pirmohamed; S Madden; B K Park
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

6.  Characterization of the UDP-glucuronosyltransferase isoenzyme expressed in rat ovary and its regulation by gonadotropins.

Authors:  L Becedas; B Lundgren; J W De Pierre
Journal:  Biochem J       Date:  1998-05-15       Impact factor: 3.857

7.  UDP-glucuronosyltransferase 1A10: activity against the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and a potential role for a novel UGT1A10 promoter deletion polymorphism in cancer susceptibility.

Authors:  Rene M Balliet; Gang Chen; Ryan W Dellinger; Philip Lazarus
Journal:  Drug Metab Dispos       Date:  2009-12-09       Impact factor: 3.922

8.  The effect of various drugs on the glucuronidation of zidovudine (azidothymidine; AZT) by human liver microsomes.

Authors:  S M Sim; D J Back; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

9.  Isolation and characterization of the monkey UGT2B30 gene that encodes a uridine diphosphate-glucuronosyltransferase enzyme active on mineralocorticoid, glucocorticoid, androgen and oestrogen hormones.

Authors:  Caroline Girard; Olivier Barbier; David Turgeon; Alain Bélanger
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

10.  Glucuronidation of tobacco-specific nitrosamines by UGT2B10.

Authors:  Gang Chen; Ryan W Dellinger; Dongxiao Sun; Thomas E Spratt; Philip Lazarus
Journal:  Drug Metab Dispos       Date:  2008-01-31       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.